Clinical trial
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients
NCT01533922
Study timeline
Study start (unknown)2012-03-01Date precision: month
Registry last updated2015-09-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Disease, Chronic Obstructiveunresolved
Interventions
PlaceboDRUG
TiotropiumDRUG · verified · RxNorm: tiotropium
OlodaterolDRUG · verified · RxNorm: olodaterol
RespimatDEVICE
Sponsors & collaborators
Boehringer Ingelheimlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01533922 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.